Alpha Teknova (TKNO) Current Assets (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Current Assets came in at $31.7 million in Q1 2026, down 20.28% year-on-year from $39.7 million in Q1 2025, and down 8.22% on a QoQ basis from $34.5 million in Q4 2025.
Alpha Teknova (TKNO) Current Assets (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Current Assets data on file, last reported at $31.7 million in Q1 2026.
- On a quarterly basis, Current Assets fell 20.28% year-over-year to $31.7 million in Q1 2026; TTM through Mar 2026 was $31.7 million, a 20.28% decrease from a year earlier, with the FY2025 full-year figure at $34.5 million, down 19.32% from the prior year.
- Current Assets for Q1 2026 stood at $31.7 million, down from $34.5 million in the prior quarter.
- Over the last five years, Current Assets for TKNO reached as high as $91.9 million in Q1 2022 and fell as low as $31.7 million in Q1 2026.
- Historically, Current Assets has averaged $49.2 million across 5 years, with a median of $43.1 million in 2023.
- Across the five-year window, Current Assets tumbled 46.29% in 2023 and rose 7.86% in 2025, its largest moves.
- Year by year, Current Assets stood at $61.1 million in 2022, then slipped by 25.32% to $45.7 million in 2023, then decreased by 6.32% to $42.8 million in 2024, then retreated by 19.32% to $34.5 million in 2025, then fell by 8.22% to $31.7 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $31.7 million in Q1 2026, $34.5 million in Q4 2025, and $36.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 31.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.67 Mn |
| Dec 31, 2025 | 34.51 Mn |
| Sep 30, 2025 | 36.56 Mn |
| Jun 30, 2025 | 38.06 Mn |
| Mar 31, 2025 | 39.73 Mn |
| Dec 31, 2024 | 42.78 Mn |
| Sep 30, 2024 | 45.93 Mn |
| Jun 30, 2024 | 35.28 Mn |
| Mar 31, 2024 | 38.82 Mn |
| Dec 31, 2023 | 45.66 Mn |
| Sep 30, 2023 | 51.08 Mn |
| Jun 30, 2023 | 43.11 Mn |
| Mar 31, 2023 | 49.63 Mn |
| Dec 31, 2022 | 61.14 Mn |
| Sep 30, 2022 | 70.07 Mn |
| Jun 30, 2022 | 80.27 Mn |
| Mar 31, 2022 | 91.94 Mn |
| Dec 31, 2021 | 101.20 Mn |
| Sep 30, 2021 | 111.08 Mn |
| Jun 30, 2021 | 118.32 Mn |